Horizon Pharma Inc (HZNP) 20.53 $HZNP Horizon P
Post# of 64074
Posted On: 02/28/2015 7:52:54 PM
Horizon Pharma Inc (HZNP) 20.53 $HZNP
Horizon Pharma raises outlook
at Investor's Business Daily - Fri Feb 27, 5:53PM CST
The specialty drugmaker's Q4 EPS was 27 cents, up from a loss a year ago and beating views by 5 cents. Revenue more than tripled to $103.8 mil, above views, on drug acquisitions. Older drug sales also rose in Q4. Horizon Pharma (HZNP) raised '15...
HZNP: 20.53 (+1.46)
J.C. Penney and Gap are big market movers
AP - Fri Feb 27, 3:55PM CST
NEW YORK (AP) — Stocks that moved substantially or traded heavily Friday on the New York Stock Exchange and the Nasdaq Stock Market:
MNST: 141.12 (+16.38), HZNP: 20.53 (+1.46), CLNE: 6.01 (+0.97)
Stocks Drop In Final Hour, But Volume Remains Tame
at Investor's Business Daily - Fri Feb 27, 3:22PM CST
Stocks settled lower in the final hour of trading to finish the session down, although the indexes finished February with strong gains. The Nasdaq closed lower by 0.5%, the S&P 500 fell 0.3% and the Dow Jones industrial average dropped 0.4%. Volume...
MNST: 141.12 (+16.38), ARUN: 24.81 (+2.20), HZNP: 20.53 (+1.46), CRI: 88.77 (+1.46), HPQ: 34.84 (+0.83), AMWD: 52.66 (+3.60)
3 Stocks Driving The Health Care Sector Higher
at The Street - Fri Feb 27, 11:12AM CST
TheStreet highlights 3 stocks pushing the health care sector higher today.
NVO: 47.75 (+0.22), BAX: 69.15 (+0.48), HZNP: 20.53 (+1.46)
Horizon Pharma's (HZNP) CEO Timothy Walbert on Q4 2014 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Fri Feb 27, 11:01AM CST
HZNP: 20.53 (+1.46)
Horizon Pharma Soars On Q4 Beat, Guidance Raise
at Investor's Business Daily - Fri Feb 27, 10:48AM CST
Specialty drugmaker Horizon Pharma (HZNP) beat analysts' Q4 expectations and raised its 2015 guidance Friday, sending its stock up 10% to a new high. Horizon's revenue in the quarter more than tripled to $103.8 million, about $8 million above...
ESRX: 84.79 (+0.25), AZN: 68.90 (-0.11), HZNP: 20.53 (+1.46), CVS: 103.87 (-0.30)
Horizon Pharma (HZNP) Stock Spikes Today on Raised Guidance Despite Quarterly Earnings Loss
at The Street - Fri Feb 27, 9:31AM CST
Horizon Pharma (HZNP) shares are up almost double digits following the company's earnings beat and revised fiscal 2015 guidance.
HZNP: 20.53 (+1.46)
Premarket Gainers / Losers as of 9:10 am
Seeking Alpha - at Seeking Alpha - Fri Feb 27, 8:15AM CST
MNST: 141.12 (+16.38), SREV: 3.72 (+0.24), OCN: 8.14 (-1.64), ARUN: 24.81 (+2.20), CVSL: 2.55 (-1.85), NBG: 1.57 (-0.16), CLNE: 6.01 (+0.97), RESN: 10.40 (-5.07), ATOS: 1.92 (-0.07), CYCC: 1.50 (+0.41), NVAX: 9.15 (-0.16), CYTX: 1.12 (-0.01), TUBE: 13.82 (-4.12), HZNP: 20.53 (+1.46), PBPB: 13.44 (-1.25), SD: 1.77 (-0.12), FRO: 2.51 (-0.27), TBIO: 1.74 (-0.47), BLOX: 23.25 (+2.02), DRL: 0.72 (-0.62), GENE: 5.83 (-0.71), MOSY: 1.80 (-0.22), XIN: 3.06 (+0.55), JCP: 8.50 (-0.62), MEET: 1.94 (unch), VIMC: 9.48 (+0.67), SPLK: 67.25 (-2.32), WTW: 11.33 (-6.23)
Horizon Pharma (HZNP) Q4 2014 Results - Earnings Call Webcast
SA Transcripts - at Seeking Alpha - Fri Feb 27, 6:55AM CST
HZNP: 20.53 (+1.46)
Horizon Pharma beats by $0.05, beats on revenue
Seeking Alpha - at Seeking Alpha - Fri Feb 27, 6:12AM CST
HZNP: 20.53 (+1.46)
Notable earnings before Friday’s open
Seeking Alpha - at Seeking Alpha - Thu Feb 26, 4:30PM CST
GLOG: 19.79 (+0.63), DFRG: 20.09 (+0.98), AAON: 22.51 (-1.06), DCIX: 2.49 (-0.01), TTI: 5.97 (+0.99), SJI: 56.68 (+0.43), CNCE: 14.39 (-1.26), XLS: 24.20 (-0.08), PNM: 28.55 (+0.23), NWN: 47.25 (-0.20), GDP: 4.48 (+0.24), HTH: 18.60 (-0.93), CAS: 3.22 (-1.81), HZNP: 20.53 (+1.46), PTCT: 71.33 (-2.13), WMC: 15.00 (+0.62), GVA: 33.12 (-1.84), CST: 41.63 (-2.38), LBY: 38.03 (+1.73), HPT: 30.81 (-0.21), KERX: 12.16 (+0.23), POM: 27.14 (-0.02), ISIS: 68.56 (+1.23), CVT: 28.95 (-0.35), HMSY: 17.54 (-1.30), NYLD: 51.31 (-1.83), RDC: 21.61 (+0.92), NRG: 23.98 (-0.79), NRF: 19.22 (-0.24)
Market Is Not In A Bubble - Cramer's Mad Money (2/23/15)
SA Editor Mohit Manghnani - Seeking Alpha - Tue Feb 24, 6:40AM CST
Stocks discussed on the in-depth session of Jim Cramer's Mad Money TV Program, Monday, February 23. With Nasdaq near all-time highs after 15 years, Cramer is listening to people talk about a new bubble forming. He said one of the good things about...
TSLA: 203.34 (-3.85), VRX: 197.48 (-3.77), CYBR: 59.27 (-3.19), AMGN: 157.72 (-1.25), INTC: 33.25 (-0.40), GOOG: 558.40 (+2.92), ORCL: 43.82 (-0.07), CELG: 121.53 (-1.82), AGEN: 4.90 (-0.14), T: 34.56 (+0.06), CTB: 38.06 (-1.11), JPM: 61.28 (-0.30), GILD: 103.53 (-0.66), HZNP: 20.53 (+1.46), GM: 37.31 (-0.25), GOOGL: 562.63 (+3.34), MSFT: 43.85 (-0.21), VZ: 49.45 (+0.08), DOW: 49.24 (-0.01), AAPL: 128.46 (-1.95), REGN: 413.84 (-6.03), CSCO: 29.51 (-0.40)
Why Horizon Pharma PLC Stock Skyrocketed Today
Todd Campbell, The Motley Fool - Motley Fool - Fri Feb 20, 1:27PM CST
Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis. What: Less than a week after presenting at a...
AZN: 68.90 (-0.11), HZNP: 20.53 (+1.46)
Market Turns Positive As Stocks Stage Reversal
at Investor's Business Daily - Fri Feb 20, 12:32PM CST
Major averages turned positive in early afternoon trading as leading medical stocks continued to dominate. The Dow Jones industrial average led with an 0.3% gain, while the Nasdaq picked up 0.2% and the S&P 500 0.1%. Volume was tracking higher across...
VRX: 197.48 (-3.77), GRUB: 42.01 (+0.26), SLXP: 157.20 (+0.25), HZNP: 20.53 (+1.46)
Next Week In Biotech: Arena And Vivus Report, Radiesse And Avedro Ad Comms
SA Editor Mike Taylor - Seeking Alpha - Fri Feb 20, 8:00AM CST
Every Friday morning, Seeking Alpha posts a calendar of the next week's expected biotech events to start a forward-looking conversation. Please be aware that dates and events can be subject to change. Please let us know in a comment or message if you...
LXRX: 0.94 (unch), AMRN: 1.51 (+0.05), HWAY: 22.38 (-0.37), HLS: 43.46 (-0.62), CYBX: 68.50 (+1.90), ESRX: 84.79 (+0.25), ECYT: 5.80 (-0.11), DXCM: 60.74 (-1.22), NSTG: 10.51 (-0.08), SRPT: 13.90 (+0.08), HZNP: 20.53 (+1.46), MDXG: 10.35 (-0.13), DEPO: 21.95 (-0.65), ANIK: 39.92 (-0.04), NKTR: 13.07 (+0.09), KERX: 12.16 (+0.23), ALIM: 5.23 (-0.05), EPZM: 23.52 (-0.08), AEGR: 27.20 (+0.20), MDRX: 12.01 (-0.74), ELGX: 15.77 (+0.09), NUVA: 45.75 (+0.76), HPTX: 29.55 (+1.82), GNMK: 12.71 (-0.19), MDVN: 117.53 (-2.21), HBIO: 5.46 (-0.09), ACAD: 37.97 (+0.19), ST: 53.74 (+0.09), RPTP: 9.27 (-0.37), FMI: 47.76 (-0.58), GMED: 24.28 (-0.78), JAZZ: 170.09 (-5.10), PTCT: 71.33 (-2.13), INFI: 15.20 (-0.84), ARNA: 4.51 (-0.24), EXEL: 2.93 (unch), NEO: 4.54 (+0.13), EXAS: 22.47 (-0.89), ALKS: 70.25 (-0.98), HTWR: 85.23 (-1.15), MNKD: 6.52 (-0.30), IPXL: 40.29 (-0.41), SQNM: 3.50 (-0.02), HALO: 15.07 (-0.21), ISIS: 68.56 (+1.23), CLVS: 76.46 (-1.43), BIO: 127.18 (+8.18), BIOS: 6.11 (+0.19), PCRX: 114.77 (-1.22)
Will ARIAD (ARIA) Impress on Iclusig Sales this Earnings? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Feb 18, 9:40AM CST
ARIAD Pharmaceuticals (ARIA) is set to report fourth-quarter 2014 results on Feb 19.
IPXL: 40.29 (-0.41), ISIS: 68.56 (+1.23), HZNP: 20.53 (+1.46), ARIA: 8.13 (-0.04)
Horizon Pharma expands US headquarters with new Chicago office
M2 - Wed Feb 18, 6:29AM CST
Biopharmaceutical company Horizon Pharma (NASDAQ:HZNP) reported on Tuesday the inauguration of its new office at Chicago, adding more than 25 jobs in the city.
HZNP: 20.53 (+1.46)
Horizon Pharma plc Expands U.S. Headquarters With Opening of Chicago Office
Marketwired - Tue Feb 17, 7:03AM CST
Horizon Pharma plc (NASDAQ: HZNP), a specialty biopharmaceutical company focused on improving patients' lives by identifying, developing, acquiring and commercializing differentiated products that address unmet medical needs, today announced it has opened a Chicago office.
HZNP: 20.53 (+1.46)
Horizon Pharma submits IND for go-ahead to start FA Phase 3
Seeking Alpha - at Seeking Alpha - Fri Feb 13, 8:15AM CST
HZNP: 20.53 (+1.46)
Technical Notes Covering Pharma Equities -- Valeant Pharma Intl., Salix Pharma, Medicines, Hospira, and Horizon Pharma
PR Newswire - Fri Feb 13, 7:45AM CST
Editor Note: For more information about this release, please scroll to bottom.
VRX: 197.48 (-3.77), MDCO: 28.76 (-0.76), HZNP: 20.53 (+1.46), SLXP: 157.20 (+0.25), HSP: 87.54 (unch), VRX.TO: 246.27 (-5.75)
Horizon Pharma raises outlook
at Investor's Business Daily - Fri Feb 27, 5:53PM CST
The specialty drugmaker's Q4 EPS was 27 cents, up from a loss a year ago and beating views by 5 cents. Revenue more than tripled to $103.8 mil, above views, on drug acquisitions. Older drug sales also rose in Q4. Horizon Pharma (HZNP) raised '15...
HZNP: 20.53 (+1.46)
J.C. Penney and Gap are big market movers
AP - Fri Feb 27, 3:55PM CST
NEW YORK (AP) — Stocks that moved substantially or traded heavily Friday on the New York Stock Exchange and the Nasdaq Stock Market:
MNST: 141.12 (+16.38), HZNP: 20.53 (+1.46), CLNE: 6.01 (+0.97)
Stocks Drop In Final Hour, But Volume Remains Tame
at Investor's Business Daily - Fri Feb 27, 3:22PM CST
Stocks settled lower in the final hour of trading to finish the session down, although the indexes finished February with strong gains. The Nasdaq closed lower by 0.5%, the S&P 500 fell 0.3% and the Dow Jones industrial average dropped 0.4%. Volume...
MNST: 141.12 (+16.38), ARUN: 24.81 (+2.20), HZNP: 20.53 (+1.46), CRI: 88.77 (+1.46), HPQ: 34.84 (+0.83), AMWD: 52.66 (+3.60)
3 Stocks Driving The Health Care Sector Higher
at The Street - Fri Feb 27, 11:12AM CST
TheStreet highlights 3 stocks pushing the health care sector higher today.
NVO: 47.75 (+0.22), BAX: 69.15 (+0.48), HZNP: 20.53 (+1.46)
Horizon Pharma's (HZNP) CEO Timothy Walbert on Q4 2014 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Fri Feb 27, 11:01AM CST
HZNP: 20.53 (+1.46)
Horizon Pharma Soars On Q4 Beat, Guidance Raise
at Investor's Business Daily - Fri Feb 27, 10:48AM CST
Specialty drugmaker Horizon Pharma (HZNP) beat analysts' Q4 expectations and raised its 2015 guidance Friday, sending its stock up 10% to a new high. Horizon's revenue in the quarter more than tripled to $103.8 million, about $8 million above...
ESRX: 84.79 (+0.25), AZN: 68.90 (-0.11), HZNP: 20.53 (+1.46), CVS: 103.87 (-0.30)
Horizon Pharma (HZNP) Stock Spikes Today on Raised Guidance Despite Quarterly Earnings Loss
at The Street - Fri Feb 27, 9:31AM CST
Horizon Pharma (HZNP) shares are up almost double digits following the company's earnings beat and revised fiscal 2015 guidance.
HZNP: 20.53 (+1.46)
Premarket Gainers / Losers as of 9:10 am
Seeking Alpha - at Seeking Alpha - Fri Feb 27, 8:15AM CST
MNST: 141.12 (+16.38), SREV: 3.72 (+0.24), OCN: 8.14 (-1.64), ARUN: 24.81 (+2.20), CVSL: 2.55 (-1.85), NBG: 1.57 (-0.16), CLNE: 6.01 (+0.97), RESN: 10.40 (-5.07), ATOS: 1.92 (-0.07), CYCC: 1.50 (+0.41), NVAX: 9.15 (-0.16), CYTX: 1.12 (-0.01), TUBE: 13.82 (-4.12), HZNP: 20.53 (+1.46), PBPB: 13.44 (-1.25), SD: 1.77 (-0.12), FRO: 2.51 (-0.27), TBIO: 1.74 (-0.47), BLOX: 23.25 (+2.02), DRL: 0.72 (-0.62), GENE: 5.83 (-0.71), MOSY: 1.80 (-0.22), XIN: 3.06 (+0.55), JCP: 8.50 (-0.62), MEET: 1.94 (unch), VIMC: 9.48 (+0.67), SPLK: 67.25 (-2.32), WTW: 11.33 (-6.23)
Horizon Pharma (HZNP) Q4 2014 Results - Earnings Call Webcast
SA Transcripts - at Seeking Alpha - Fri Feb 27, 6:55AM CST
HZNP: 20.53 (+1.46)
Horizon Pharma beats by $0.05, beats on revenue
Seeking Alpha - at Seeking Alpha - Fri Feb 27, 6:12AM CST
HZNP: 20.53 (+1.46)
Notable earnings before Friday’s open
Seeking Alpha - at Seeking Alpha - Thu Feb 26, 4:30PM CST
GLOG: 19.79 (+0.63), DFRG: 20.09 (+0.98), AAON: 22.51 (-1.06), DCIX: 2.49 (-0.01), TTI: 5.97 (+0.99), SJI: 56.68 (+0.43), CNCE: 14.39 (-1.26), XLS: 24.20 (-0.08), PNM: 28.55 (+0.23), NWN: 47.25 (-0.20), GDP: 4.48 (+0.24), HTH: 18.60 (-0.93), CAS: 3.22 (-1.81), HZNP: 20.53 (+1.46), PTCT: 71.33 (-2.13), WMC: 15.00 (+0.62), GVA: 33.12 (-1.84), CST: 41.63 (-2.38), LBY: 38.03 (+1.73), HPT: 30.81 (-0.21), KERX: 12.16 (+0.23), POM: 27.14 (-0.02), ISIS: 68.56 (+1.23), CVT: 28.95 (-0.35), HMSY: 17.54 (-1.30), NYLD: 51.31 (-1.83), RDC: 21.61 (+0.92), NRG: 23.98 (-0.79), NRF: 19.22 (-0.24)
Market Is Not In A Bubble - Cramer's Mad Money (2/23/15)
SA Editor Mohit Manghnani - Seeking Alpha - Tue Feb 24, 6:40AM CST
Stocks discussed on the in-depth session of Jim Cramer's Mad Money TV Program, Monday, February 23. With Nasdaq near all-time highs after 15 years, Cramer is listening to people talk about a new bubble forming. He said one of the good things about...
TSLA: 203.34 (-3.85), VRX: 197.48 (-3.77), CYBR: 59.27 (-3.19), AMGN: 157.72 (-1.25), INTC: 33.25 (-0.40), GOOG: 558.40 (+2.92), ORCL: 43.82 (-0.07), CELG: 121.53 (-1.82), AGEN: 4.90 (-0.14), T: 34.56 (+0.06), CTB: 38.06 (-1.11), JPM: 61.28 (-0.30), GILD: 103.53 (-0.66), HZNP: 20.53 (+1.46), GM: 37.31 (-0.25), GOOGL: 562.63 (+3.34), MSFT: 43.85 (-0.21), VZ: 49.45 (+0.08), DOW: 49.24 (-0.01), AAPL: 128.46 (-1.95), REGN: 413.84 (-6.03), CSCO: 29.51 (-0.40)
Why Horizon Pharma PLC Stock Skyrocketed Today
Todd Campbell, The Motley Fool - Motley Fool - Fri Feb 20, 1:27PM CST
Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis. What: Less than a week after presenting at a...
AZN: 68.90 (-0.11), HZNP: 20.53 (+1.46)
Market Turns Positive As Stocks Stage Reversal
at Investor's Business Daily - Fri Feb 20, 12:32PM CST
Major averages turned positive in early afternoon trading as leading medical stocks continued to dominate. The Dow Jones industrial average led with an 0.3% gain, while the Nasdaq picked up 0.2% and the S&P 500 0.1%. Volume was tracking higher across...
VRX: 197.48 (-3.77), GRUB: 42.01 (+0.26), SLXP: 157.20 (+0.25), HZNP: 20.53 (+1.46)
Next Week In Biotech: Arena And Vivus Report, Radiesse And Avedro Ad Comms
SA Editor Mike Taylor - Seeking Alpha - Fri Feb 20, 8:00AM CST
Every Friday morning, Seeking Alpha posts a calendar of the next week's expected biotech events to start a forward-looking conversation. Please be aware that dates and events can be subject to change. Please let us know in a comment or message if you...
LXRX: 0.94 (unch), AMRN: 1.51 (+0.05), HWAY: 22.38 (-0.37), HLS: 43.46 (-0.62), CYBX: 68.50 (+1.90), ESRX: 84.79 (+0.25), ECYT: 5.80 (-0.11), DXCM: 60.74 (-1.22), NSTG: 10.51 (-0.08), SRPT: 13.90 (+0.08), HZNP: 20.53 (+1.46), MDXG: 10.35 (-0.13), DEPO: 21.95 (-0.65), ANIK: 39.92 (-0.04), NKTR: 13.07 (+0.09), KERX: 12.16 (+0.23), ALIM: 5.23 (-0.05), EPZM: 23.52 (-0.08), AEGR: 27.20 (+0.20), MDRX: 12.01 (-0.74), ELGX: 15.77 (+0.09), NUVA: 45.75 (+0.76), HPTX: 29.55 (+1.82), GNMK: 12.71 (-0.19), MDVN: 117.53 (-2.21), HBIO: 5.46 (-0.09), ACAD: 37.97 (+0.19), ST: 53.74 (+0.09), RPTP: 9.27 (-0.37), FMI: 47.76 (-0.58), GMED: 24.28 (-0.78), JAZZ: 170.09 (-5.10), PTCT: 71.33 (-2.13), INFI: 15.20 (-0.84), ARNA: 4.51 (-0.24), EXEL: 2.93 (unch), NEO: 4.54 (+0.13), EXAS: 22.47 (-0.89), ALKS: 70.25 (-0.98), HTWR: 85.23 (-1.15), MNKD: 6.52 (-0.30), IPXL: 40.29 (-0.41), SQNM: 3.50 (-0.02), HALO: 15.07 (-0.21), ISIS: 68.56 (+1.23), CLVS: 76.46 (-1.43), BIO: 127.18 (+8.18), BIOS: 6.11 (+0.19), PCRX: 114.77 (-1.22)
Will ARIAD (ARIA) Impress on Iclusig Sales this Earnings? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Feb 18, 9:40AM CST
ARIAD Pharmaceuticals (ARIA) is set to report fourth-quarter 2014 results on Feb 19.
IPXL: 40.29 (-0.41), ISIS: 68.56 (+1.23), HZNP: 20.53 (+1.46), ARIA: 8.13 (-0.04)
Horizon Pharma expands US headquarters with new Chicago office
M2 - Wed Feb 18, 6:29AM CST
Biopharmaceutical company Horizon Pharma (NASDAQ:HZNP) reported on Tuesday the inauguration of its new office at Chicago, adding more than 25 jobs in the city.
HZNP: 20.53 (+1.46)
Horizon Pharma plc Expands U.S. Headquarters With Opening of Chicago Office
Marketwired - Tue Feb 17, 7:03AM CST
Horizon Pharma plc (NASDAQ: HZNP), a specialty biopharmaceutical company focused on improving patients' lives by identifying, developing, acquiring and commercializing differentiated products that address unmet medical needs, today announced it has opened a Chicago office.
HZNP: 20.53 (+1.46)
Horizon Pharma submits IND for go-ahead to start FA Phase 3
Seeking Alpha - at Seeking Alpha - Fri Feb 13, 8:15AM CST
HZNP: 20.53 (+1.46)
Technical Notes Covering Pharma Equities -- Valeant Pharma Intl., Salix Pharma, Medicines, Hospira, and Horizon Pharma
PR Newswire - Fri Feb 13, 7:45AM CST
Editor Note: For more information about this release, please scroll to bottom.
VRX: 197.48 (-3.77), MDCO: 28.76 (-0.76), HZNP: 20.53 (+1.46), SLXP: 157.20 (+0.25), HSP: 87.54 (unch), VRX.TO: 246.27 (-5.75)
(0)
(0)Scroll down for more posts ▼